案例报告:认知功能障碍的特征以及神经元内核包容性疾病中抗发作药物的改善
Hiroya Ohara1, Masami Yamanaka2, Fumi Okada3
1Department of Neurology, Minaminara General Medical Center, Yoshino, Nara, Japan.
Frontiers in neuroscience
|February 20, 2026
概括
非性状态 (NCSE) 可以使神经内核包容性疾病 (NIID) 的认知衰退恶化. 抗发作药物 (ASM) 改善了认知功能,特定的绘画和写作测试有助于区分NIID和阿尔茨海默病 (AD).
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 病理学 病理学 病理学
背景情况:
- 神经内核包容性疾病 (NIID) 是一种罕见的,进展性神经退行性疾病.
- 认知功能障碍是关键特征,但其进展和与阿尔茨海默病 (AD) 等其他痴呆症的区分仍然具有挑战性.
- 非性状态 (NCSE) 在加速NIID认知衰退中的作用尚未完全理解.
研究的目的:
- 调查NCSE对病理确诊NIID认知功能障碍的影响.
- 确定独特的临床和诊断因素来区分NIID和AD.
- 评估抗发作药物 (ASM) 对NCSENIID患者认知功能的影响.
主要方法:
- 一个63岁的男性患有痴呆主导性零星NIID的病例研究,呈现出暂时的意识障碍.
- 临床特征分析,神经学检查结果,脑电图 (EEG),磁共振成像 (MRI) 和微型精神状态检查 (MMSE) 成绩.
- 评估对ASM的反应,并通过皮肤活检确认NIID诊断.
- 叙述文献综述用于与AD进行比较分析.
主要成果:
- 患者表现出波动性的认知能力下降,包括迷失方向,记忆障碍,失言症,偏敏症和视觉空间能力受损 (MMSE分数为10).
- EEG显示了发作模式,表明NCSE,而MRI显示了非特定的发现.
- 用ASM治疗改善了MMSE得分,达到23,表明积极反应.
- 独特的特征包括视觉空间缺陷 (五角形绘图受损) 和 agraphia (kanji和kana),使其与AD的呈现不同.
结论:
- 在NIID中,NCSE可以显著加速认知衰退.
- 在NIID患者中,ASM可以导致认知功能的可测量改善.
- 特定的认知评估,如五角形绘图和手写分析 (kanji/kana),可以作为有价值的工具来区分NIID和AD.
相关概念视频
Neural Regulation
34.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
34.8K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
933
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
933
Epilepsy and Seizures: Overview
1.8K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.8K
Antiepileptic Drugs: Potassium Channel Activators
1.0K
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
1.0K
Encephalitis l: Introduction
29
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
29
Epilepsy ll: Types
73
Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
73


